GOLDMAN SACHS GROUP INC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 69 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$502,000
-36.6%
117,493
-42.5%
0.00%
Q2 2022$792,000
+10.5%
204,164
+35.5%
0.00%
Q1 2022$717,000
+2.1%
150,689
-21.6%
0.00%
Q4 2021$702,000
-48.9%
192,251
+12.3%
0.00%
Q3 2021$1,373,000
-53.7%
171,194
-34.5%
0.00%
-100.0%
Q2 2021$2,966,000
-46.9%
261,513
-56.7%
0.00%0.0%
Q1 2021$5,587,000603,9740.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,232,0000.82%
Samsara BioCapital, LLC 689,709$2,945,0000.69%
BVF INC/IL 3,614,662$15,435,0000.64%
Rubric Capital Management LP 994,801$4,248,0000.21%
HAMILTON LANE ADVISORS LLC 35,791$153,0000.06%
MAI Capital Management 637,641$2,723,0000.05%
Jasper Ridge Partners, L.P. 92,939$397,0000.03%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$88,0000.02%
Ergoteles LLC 132,636$566,0000.02%
Laurion Capital Management LP 698,000$2,980,0000.02%
View complete list of VIRACTA THERAPEUTICS INC shareholders